While physicians said chaotic work environments are to blame for their burnout, nurses cited after-hours workloads, according to a recent report from KLAS Research’s Arch Collaborative.
The payer filed suit Monday against Gilead, Teva, Janssen and Bristol Myers Squibb, alleging the drugmakers conspired to protect the market dominance of lucrative HIV medications despite the existence of generic alternatives.
The longtime CEO is now set to be replaced by the end of next year, and a new policy mandates a board retirement age of 75.
Full study results show Paxlovid cut the risk of COVID-19 hospitalization or death by about 90% among high-risk adults, matching the interim findings the drugmaker disclosed last month.
The lawsuit was filed by a group of doctors and other medical professionals protesting that the state’s requirement for staff in hospitals, long-term care and other healthcare facilities does not allow for a religious exemption.
Companies across the healthcare spectrum are pursuing deals to strengthen operations after two years of pandemic-driven challenges, a new PwC report found.
Preliminary laboratory testing by Pfizer and partner BioNTech indicated three doses may protect against omicron as well as two doses perform against the original coronavirus strain.
But more recently, confounding factors such as healthcare staffing shortages are causing the delta variant headwind to drag on. Rapidly increasing inpatient volumes are leading some U.S. hospitals to again delay surgical procedures.
After months of contentious negotiations, workers have agreed to a new contract that secures wage increases and safe staffing commitments.
CVS wants to broaden its care delivery strategy, including “physician-led primary care centers with integrated virtual and home assets,” CVS EVP and president of pharmacy services Alan Lotvin said Thursday.